• MedicalDevice

    In Vitro Standards & Custom Assays

    Oroxcell offers alternative in vitro toxicology assays to help understand the safety profile of your medical device and support your dossiers. These will identify and evaluate any existing toxicity and human exposure risks for the final product and individual chemical compounds, mixtures and or extracts.

    Since 2004, Oroxcell has been involved for the development and validation of In vitro / In chemico assays that reached scientific and quality criteria to support critical toxicological end points according to existing OECD guidelines, and also to develop and validate novel assays permitting the assessment of novel endpoints or products that cannot accurately be tested using existing guidelines.

    broken image
  • In Vitro ADME

    In Vitro Absorption

    In Vitro Metabolism

    • Hepatic Metabolism
    • Extra Hepatic Metabolism

    In Vitro Distribution

     

  • In Vitro Toxicology

    Cutaneous Absorption

    • Tissue Absorption
    • Tissue Distribution

    Sensitisation

    • DPRA LCMMS OECD 442C
    • RHE IL-18
    • H-ClaT

    Genotoxicity

    • Micronucleous OECD
    • RHE Micronucleus
    • Ames OECD 442C

    Phototoxicity

    • 3T3 OECD
    • RHE Phototoxicity
    • Photosensitisation

    Sensitisation

    • DPRA LCMMS OECD 442C
    • RHE IL-18
    • H-ClaT

  • Click on image to enhance product description

  • Partnership based Developments

    Tailor-Made Tests

  • Efficacy/Pharmacology

    Tailor-Made Tests

  • Any Request ?